| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu City 500-8705, Japan
Address all correspondence and requests for reprints to: Jiro Fujimoto, M.D., Ph.D., Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City 500-8705, Japan.
Platelet-derived endothelial cell growth factor (PD-ECGF) is expressed in the lining epithelial cells of ovarian endometriomas, and in interstitial cells of the subepithelial area with angiogenesis. The expression of PD-ECGF persists in endometriotic endometrium during the menstrual cycle. This might suggest that PD-ECGF contributes to the growth of ovarian endometriomas via subepithelial angiogenesis independently of the sex steroidal milieu.
This article has been cited by other articles:
![]() |
G. Zhang, N. Dmitrieva, Y. Liu, K. A. McGinty, and K. J. Berkley Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R162 - R171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Laschke and M. D. Menger In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis Hum. Reprod. Update, July 1, 2007; 13(4): 331 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Becker, R. D. Wright, R. Satchi-Fainaro, T. Funakoshi, J. Folkman, A. L. Kung, and R. J. D'Amato A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy Am. J. Pathol., June 1, 2006; 168(6): 2074 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.W. Laschke, A. Elitzsch, B. Vollmar, P. Vajkoczy, and M.D. Menger Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions Hum. Reprod., January 1, 2006; 21(1): 262 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kats, C. N. Metz, and A. Akoum Macrophage Migration Inhibitory Factor Is Markedly Expressed in Active and Early-Stage Endometriotic Lesions J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 883 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Alcazar Transvaginal colour Doppler in patients with ovarian endometriomas and pelvic pain Hum. Reprod., December 1, 2001; 16(12): 2672 - 2675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fujimoto, H. Sakaguchi, I. Aoki, and T. Tamaya The Value of Platelet-derived Endothelial Cell Growth Factor as a Novel Predictor of Advancement of Uterine Cervical Cancers Cancer Res., July 1, 2000; 60(13): 3662 - 3665. [Abstract] [Full Text] |
||||
![]() |
J. Fujimoto, H. Sakaguchi, R. Hirose, H. Wen, and T. Tamaya Clinical Implication of Expression of Platelet-derived Endothelial Cell Growth Factor (PD-ECGF) in Metastatic Lesions of Uterine Cervical Cancers Cancer Res., July 1, 1999; 59(13): 3041 - 3044. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |